Kallistatin, a novel human tissue kallikrein inhibitor: Levels in body fluids, blood cells, and tissues in health and disease

Journal of Laboratory and Clinical Medicine

Volumn 127, Issue 6, 1996, Pages 612-620

  Chao, Julie ^a   Schmaier, Alvin ^b   Chen, Li Mei ^b   Yang, Zhirong ^b   Chao, Lee ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030174627     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90152-3     Document Type: Article

References (35)

1. Clements JA. The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr Rev 1989;10:393-419.
2. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80.
3. Schachter M. Kallikreins (kininogenases): a group of serine proteases with bioregulatory actions. Pharmacol Rev 1980; 31:7-17.
4. Scicli AG, Carretera OA. Renal kallikrein-kinin system. Kidney Int 1986;29:120-30.
5. MacDonald RJ, Margolius HS, Erdos EG. Molecular biology of tissue kallikrein. Biochem J 1988;253:313-21.
6. Chao J, Chai KX, Chen L-M, et al. Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J Biol Chem 1990;265:16394-401.
7. Zhou GX, Chao L, Chao J. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence. J Biol Chem 1992;267:25873-80.
8. Chai KX, Chen L-M, Chao J, Chao L. Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli. J Biol Chem 1993;268:24498-505.
9. Chai KX, Ma J-X, Murray SR, Chao J, Chao J. Molecular cloning and analysis of the rat kallikrein-binding protein gene. J Biol Chem 1991;266:16029-36.
10. Xiong W, Tang CQ, Zhou GX, Chao L, Chao J. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein. J Lab Clin Med 1992;119:514-21.
11. Le Cam A, Pages G, Auberger P, et al. Study of a growth hormone-regulated protein secreted by rat hepatocytes: cDNA cloning, anti-protease activity and regulation of its synthesis by various hormones. EMBO J 1987;6:1225-32.
12. Tecce MF, Dozin B, Magnuson MA, Nikodem VM. Transcriptional regulation by thyroid hormone of an mRNA homologous to a protease inhibitor. Biochemistry 1986;25:5831-4.
13. Yoon JB, Towle HC, Seelig S. Growth hormone induces two mRNA species of the serine protease inhibitor gene family in rat liver. J Biol Chem 1987;262:4284-9.
14. Lu HS, Lin FK, Chao L, Chao J. Human urinary kallikrein. Complete amino acid sequence and sites of glycosylation. Int J Pept Protein Res 1989;33:237-49.
15. Chao J, Chao L, Tillman DM, Woodley CM, Margolius HS. Characterization of monoclonal and polyclonal antibodies to human tissue kallikrein. Hypertension 1985;7:931-7.
16. Lowry OH, Rosebrough NF, Farr AG, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;93:265-75.
17. Chibber G, Cohen A, Lane S, Farber A, Meloni FJ, Schmaier AH. Immunoblotting of plasma in a pregnant patient with hereditary angioedema. J Lab Clin Med 1988;115:112-21.
18. Schmaier AH, Farber A, Schein R, Sprung C. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis. J Lab Clin Med 1988;112:182-92.
19. 2-Macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood 1991;77:2660-7.
20. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 1984;25:383-90.
21. Baird AW, Miller DH, Schwartz DA, Margolius HS. Enhancement of kallikrein production and kinin sensitivity in T84 cells by growth in the nude mouse. Am J Physiol 1991; 261:C822-7.
22. Griffith RL, Virella GT, Stevenson HC, Lopes-Virella MF. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes - a possible mechanism of foam cell formation. J Exp Med 1988; 168:1041-59.
23. Guesdon JL, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979;27:1131-9.
24. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
25. Wang J, Xiong W, Yang Z, et al. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 1994; 23:236-43.
26. Chao J, Chao L. Biochemistry, regulation and potential function of kallistatin. Biol Chem Hoppe Seyler 1995;376:705-13.
27. Schmaier AH, Smith PM, Colman RW. Platelet C1-inhibitor. A secreted alpha-granule protein. J Clin Invest 1975;75:242-50.
28. Bagdasarian A, Colman RW. Subcellular localization and purification of platelet alpha 1-antitrypsin. Blood 1978;51: 139-56.
29. Plow EF, Collen D. The presence and release of alpha 2-antiplasmin from human platelets. Blood 1981;58:1069-74.
30. Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science 1990;248:745-8.
31. Erickson LA, Ginsberg MH, Loskutoff DJ. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984;74:1465-72.
32. Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG, Bajaj SP. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci 1990;87:8869-73.
33. Chao J, Chao L. A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats. J Hypertens 1988;6:551-7.
34. Lindpaintner K, Chai KX, Kreutz R, et al. Differential levels of kallikrein-binding protein (KBP) and cosegregation of the KBP-locus with blood pressure response to sodium in genetically hypertensive rats. Fifteenth Scientific Meeting of the International Society of Hypertension, Melbourne, Australia, 1994.
35. Ma J, Yang Z, Chao J, Chao L. Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J Biol Chem 1995;270:451-5.